Regulatory T Cell Therapies Research Group

2019 Ooi group
2019 Ooi Group L-R: Ms Janet Chang, Ms Rachel Cheong, Ms Chanjuan Shen, Mr Peter Eggenhuizen, Dr Joshua Ooi

Group Head

Dr Joshua Ooi

Dr Joshua Ooi is an Al and Val Rosenstrauss Fellow at the School of Clinical Sciences. His laboratory focusses on generating autoantigen-specific regulatory T cells to treat autoimmune diseases.

During his PhD (2009) and post-doctoral training, Dr. Ooi showed that inflammatory T helper cells specific for self proteins (known as autoantigens) underlie the pathogenesis of autoimmune disease. Now, Dr. Ooi and his team are devising regulatory T cell based therapies that specifically switch off the autoantigen-specific inflammatory response.

His work has been published in the top journals including in PNAS, J Clin Invest and Nature; and he has received funding by the NHMRC, Rebecca Cooper Medical Research Foundation and the Lupus Research Alliance to develop these new and innovative therapies.

Our staff

Researcher

Other staff and students

Janet Chang

Janet Chang
Research Officer

Peter Eggenhuizen

Peter Eggenhuizen
Lab Manager

Rachel Cheong

Rachel Cheong
PhD student

Chanjuan Shen

Chanjuan Shen
Visiting Fellow